Gareth Burton folgt Thomas Bachmaier als think project! CEO
think project!, führender Anbieter eines cloudbasierten Common Data Environment (CDE) für Bau- und Ingenieurprojekte, ga…
think project!, führender Anbieter eines cloudbasierten Common Data Environment (CDE) für Bau- und Ingenieurprojekte, ga…
Kuros Biosciences (SIX: KURN) will propose the re-appointment of Clemens van Blitterswijk as Chairman of the Board of Di…
Polyphor has started PRISM-UDR Phase III clinical trial of the pathogen-specific antibiotic murepavadin in patients with…
Chief Medical and Development Officer Debra Barker has decided to leave Polyphor at year end for personal reasons and wi…
IPO an der SIX Swiss Exchange, Bruttoerlös von CHF 155 Mio. Murepavadin startet Phase III Balixafortide erhält Fast Tra…
Novo REPAIR Impact Fund investiert bis zu CHF 11.5 Mio. in die OMPTA-Pipeline von Polyphor, dies über eine Beteiligung v…
Kuros announced that today’s General Meeting approved all resolutions proposed by the Board of Directors with a clear ma…
Kuros Biosciences (SIX: KURN) will propose the appointment of CEO Joost de Bruijn, as well as three new independent non-…
Polyphor gab heute bekannt, dass die amerikanische Gesundheitsbehörde FDA dem neuartigen Immunonkologie-Wirkstoff Balix…
Polyphor has been selected by the Access to Medicine Foundation as one of the leading companies in the area of research…